{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T14:48:44Z","timestamp":1772808524802,"version":"3.50.1"},"reference-count":68,"publisher":"Public Library of Science (PLoS)","issue":"8","license":[{"start":{"date-parts":[[2013,8,28]],"date-time":"2013-08-28T00:00:00Z","timestamp":1377648000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0072148","type":"journal-article","created":{"date-parts":[[2013,8,28]],"date-time":"2013-08-28T17:20:45Z","timestamp":1377710445000},"page":"e72148","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":39,"title":["Drug-Induced Acute Myocardial Infarction: Identifying \u2018Prime Suspects\u2019 from Electronic Healthcare Records-Based Surveillance System"],"prefix":"10.1371","volume":"8","author":[{"given":"Preciosa M.","family":"Coloma","sequence":"first","affiliation":[]},{"given":"Martijn J.","family":"Schuemie","sequence":"additional","affiliation":[]},{"given":"Gianluca","family":"Trifir\u00f2","sequence":"additional","affiliation":[]},{"given":"Laura","family":"Furlong","sequence":"additional","affiliation":[]},{"given":"Erik","family":"van Mulligen","sequence":"additional","affiliation":[]},{"given":"Anna","family":"Bauer-Mehren","sequence":"additional","affiliation":[]},{"given":"Paul","family":"Avillach","sequence":"additional","affiliation":[]},{"given":"Jan","family":"Kors","sequence":"additional","affiliation":[]},{"given":"Ferran","family":"Sanz","sequence":"additional","affiliation":[]},{"given":"Jordi","family":"Mestres","sequence":"additional","affiliation":[]},{"given":"Jos\u00e9 Luis","family":"Oliveira","sequence":"additional","affiliation":[]},{"given":"Scott","family":"Boyer","sequence":"additional","affiliation":[]},{"given":"Ernst Ahlberg","family":"Helgee","sequence":"additional","affiliation":[]},{"given":"Mariam","family":"Molokhia","sequence":"additional","affiliation":[]},{"given":"Justin","family":"Matthews","sequence":"additional","affiliation":[]},{"given":"David","family":"Prieto-Merino","sequence":"additional","affiliation":[]},{"given":"Rosa","family":"Gini","sequence":"additional","affiliation":[]},{"given":"Ron","family":"Herings","sequence":"additional","affiliation":[]},{"given":"Giampiero","family":"Mazzaglia","sequence":"additional","affiliation":[]},{"given":"Gino","family":"Picelli","sequence":"additional","affiliation":[]},{"given":"Lorenza","family":"Scotti","sequence":"additional","affiliation":[]},{"given":"Lars","family":"Pedersen","sequence":"additional","affiliation":[]},{"given":"Johan","family":"van der Lei","sequence":"additional","affiliation":[]},{"given":"Miriam","family":"Sturkenboom","sequence":"additional","affiliation":[]},{"name":"on behalf of the EU-ADR consortium","sequence":"additional","affiliation":[]}],"member":"340","published-online":{"date-parts":[[2013,8,28]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"2002","DOI":"10.1056\/NEJMsa1103053","article-title":"Emergency hospitalizations for adverse drug events in older Americans","volume":"365","author":"DS Budnitz","year":"2011","journal-title":"N Engl J Med"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/S1553-7250(12)38016-1","article-title":"The costs of adverse drug events in community hospitals","volume":"38","author":"BL Hug","year":"2012","journal-title":"Jt Comm J Qual Patient Saf"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1258\/jrsm.2010.100113","article-title":"Ten-year trends in hospital admissions for adverse drug reactions in England 1999\u20132009","volume":"103","author":"TY Wu","year":"2010","journal-title":"J R Soc Med"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1136\/bmj.312.7040.1215","article-title":"Why we need observational studies to evaluate the effectiveness of health care","volume":"312","author":"N Black","year":"1996","journal-title":"BMJ"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1503\/cmaj.050873","article-title":"Comparison of evidence on harms of medical interventions in randomized and nonrandomized studies","volume":"174","author":"PN Papanikolaou","year":"2006","journal-title":"CMAJ"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1056\/NEJMp038145","article-title":"Population-based studies of adverse drug effects","volume":"349","author":"WA Ray","year":"2003","journal-title":"N Engl J Med"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1056\/NEJMp0905338","article-title":"The new Sentinel Network\u2013improving the evidence of medical-product safety","volume":"361","author":"R Platt","year":"2009","journal-title":"N Engl J Med"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/pds.2053","article-title":"Combining electronic healthcare databases in Europe to allow for large-scale drug safety monitoring: the EU-ADR Project","volume":"20","author":"PM Coloma","year":"2011","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"600","DOI":"10.7326\/0003-4819-153-9-201011020-00010","article-title":"Advancing the science for active surveillance: rationale and design for the Observational Medical Outcomes Partnership","volume":"153","author":"PE Stang","year":"2010","journal-title":"Ann Intern Med"},{"key":"ref10","unstructured":"The Uppsala Monitoring Centre. WHO Global Database Reaches 7 Million."},{"key":"ref11","unstructured":"US Food and Drug Administration. Reports received and entered into AERS by year."},{"key":"ref12","doi-asserted-by":"crossref","first-page":"459","DOI":"10.2165\/00002018-200225060-00011","article-title":"Signal selection and follow-up in pharmacovigilance","volume":"25","author":"RH Meyboom","year":"2002","journal-title":"Drug Saf"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"843","DOI":"10.2165\/00002018-200528100-00002","article-title":"Impact analysis of signals detected from spontaneous adverse drug reaction reporting data","volume":"28","author":"P Waller","year":"2005","journal-title":"Drug Saf"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"901","DOI":"10.2165\/00002018-200528100-00006","article-title":"Testing and implementing signal impact analysis in a regulatory setting: results of a pilot study","volume":"28","author":"E Heeley","year":"2005","journal-title":"Drug Saf"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"727","DOI":"10.2165\/00002018-200831090-00001","article-title":"A model for decision support in signal triage","volume":"31","author":"B Levitan","year":"2008","journal-title":"Drug Saf"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"635","DOI":"10.2165\/00002018-200730070-00014","article-title":"Use of triage strategies in the WHO signal-detection process","volume":"30","author":"M Lindquist","year":"2007","journal-title":"Drug Saf"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1097\/01.hjh.0000186832.41125.8a","article-title":"Patterns of persistence with antihypertensive medications in newly diagnosed hypertensive patients in Italy: a retrospective cohort study in primary care","volume":"23","author":"G Mazzaglia","year":"2005","journal-title":"J Hypertens"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1055\/s-0038-1634402","article-title":"Postmarketing surveillance based on electronic patient records: the IPCI project","volume":"38","author":"AE Vlug","year":"1999","journal-title":"Methods Inf Med"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"e26","DOI":"10.1542\/peds.2004-0040","article-title":"Incidence of mucocutaneous reactions in children treated with niflumic acid, other nonsteroidal antiinflammatory drugs, or nonopioid analgesics","volume":"116","author":"M Sturkenboom","year":"2005","journal-title":"Pediatrics"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1111\/j.1365-2036.2007.03274.x","article-title":"Introduction of newer selective cyclo-oxygenase-2 inhibitors and rates of hospitalization with bleeding and perforated peptic ulcer","volume":"25","author":"S Christensen","year":"2007","journal-title":"Aliment Pharmacol Ther"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1002\/pds.1245","article-title":"Developments of the incidence of osteoporosis in The Netherlands: a PHARMO study","volume":"16","author":"WG Goettsch","year":"2007","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1093\/annonc\/mdm404","article-title":"Menopause hormone replacement therapy and cancer risk: an Italian record linkage investigation","volume":"19","author":"G Corrao","year":"2008","journal-title":"Ann Oncol"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.ijcard.2006.01.006","article-title":"Early discharge after acute myocardial infarction in the current clinical practice. Community data from the AMI-Florence Registry, Italy","volume":"114","author":"A Barchielli","year":"2007","journal-title":"Int J Cardiol"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1002\/pds.3197","article-title":"Electronic healthcare databases for active drug safety surveillance: is there enough leverage?","volume":"21","author":"PM Coloma","year":"2012","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"ref25","first-page":"1085","article-title":"Design and evaluation of a semantic approach for the homogeneous identification of events in eight patient databases: a contribution to the European EU-ADR project","volume":"160","author":"P Avillach","year":"2010","journal-title":"Stud Health Technol Inform"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1136\/amiajnl-2012-000933","article-title":"Harmonization process for the identification of medical events in eight European healthcare databases: the experience from the EU-ADR project","volume":"20","author":"P Avillach","year":"2013","journal-title":"J Am Med Inform Assoc"},{"key":"ref27","doi-asserted-by":"crossref","unstructured":"Coloma PM, Valkhoff VE, Mazzaglia G, Nielsson MS, Pedersen L, <etal>et al<\/etal>.. (2013) Identification of acute myocardial infarction from electronic healthcare records using different disease coding systems: a validation study in three European countries. BMJ Open 3.","DOI":"10.1136\/bmjopen-2013-002862"},{"key":"ref28","doi-asserted-by":"crossref","unstructured":"Schuemie MJ, Coloma PM, Straatman H, Herings RM, Trifiro G, <etal>et al<\/etal>.. (2012) Using Electronic Health Care Records for Drug Safety Signal Detection: A Comparative Evaluation of Statistical Methods. Med Care.","DOI":"10.1097\/MLR.0b013e31825f63bf"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1002\/pds.2051","article-title":"Methods for drug safety signal detection in longitudinal observational databases: LGPS and LEOPARD","volume":"20","author":"MJ Schuemie","year":"2011","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"e1002457","DOI":"10.1371\/journal.pcbi.1002457","article-title":"Automatic filtering and substantiation of drug safety signals","volume":"8","author":"A Bauer-Mehren","year":"2012","journal-title":"PLoS Comput Biol"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1002\/pds.3375","article-title":"The EU-ADR Web Platform: delivering advanced pharmacovigilance tools","volume":"22","author":"JL Oliveira","year":"2013","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"99","DOI":"10.2165\/00002018-200932020-00003","article-title":"Defining \u2018signal\u2019 and its subtypes in pharmacovigilance based on a systematic review of previous definitions","volume":"32","author":"M Hauben","year":"2009","journal-title":"Drug Saf"},{"key":"ref33","first-page":"295","article-title":"The Environment and Disease: Association or Causation?","volume":"58","author":"AB Hill","year":"1965","journal-title":"Proc R Soc Med"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"805","DOI":"10.2165\/11532460-000000000-00000","article-title":"Reflections on attribution and decisions in pharmacovigilance","volume":"33","author":"O Caster","year":"2010","journal-title":"Drug Saf"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.2217\/14622416.8.11.1479","article-title":"\u2018Drug reactions, enzymes, and biochemical genetics\u2019: 50 years later","volume":"8","author":"D Gurwitz","year":"2007","journal-title":"Pharmacogenomics"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1136\/bmj.329.7456.44","article-title":"Detection, verification, and quantification of adverse drug reactions","volume":"329","author":"BH Stricker","year":"2004","journal-title":"BMJ"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"649","DOI":"10.2165\/00002018-200225090-00004","article-title":"Effects of HMG-CoA reductase inhibitors on skeletal muscle: are all statins the same?","volume":"25","author":"M Evans","year":"2002","journal-title":"Drug Saf"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1111\/j.1742-1241.1991.tb10251.x","article-title":"Histamine-induced coronary artery spasm: the concept of allergic angina","volume":"45","author":"NG Kounis","year":"1991","journal-title":"Br J Clin Pract"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1586\/eci.10.47","article-title":"Current understanding of Kounis syndrome","volume":"6","author":"M Biteker","year":"2010","journal-title":"Expert Rev Clin Immunol"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1161\/01.CIR.92.5.1084","article-title":"Infiltrates of activated mast cells at the site of coronary atheromatous erosion or rupture in myocardial infarction","volume":"92","author":"PT Kovanen","year":"1995","journal-title":"Circulation"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"11","DOI":"10.2174\/187152809787582462","article-title":"Kounis syndrome following beta-lactam antibiotic use: review of literature","volume":"8","author":"M Ridella","year":"2009","journal-title":"Inflamm Allergy Drug Targets"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"2840","DOI":"10.2174\/138161208786369812","article-title":"Macrolides allergy","volume":"14","author":"L Araujo","year":"2008","journal-title":"Curr Pharm Des"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"77","DOI":"10.4168\/aair.2010.2.2.77","article-title":"Update on the management of antibiotic allergy","volume":"2","author":"BY Thong","year":"2010","journal-title":"Allergy Asthma Immunol Res"},{"key":"ref44","first-page":"202","article-title":"Drug hypersensitivities: definition, epidemiology and risk factors","volume":"37","author":"P Demoly","year":"2005","journal-title":"Eur Ann Allergy Clin Immunol"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1007\/s11883-012-0226-3","article-title":"Coronary heart disease in young adults","volume":"14","author":"JB Rubin","year":"2012","journal-title":"Curr Atheroscler Rep"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/j.jcin.2009.04.017","article-title":"Drug-eluting stent thrombosis: the Kounis hypersensitivity-associated acute coronary syndrome revisited","volume":"2","author":"JP Chen","year":"2009","journal-title":"JACC Cardiovasc Interv"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"73","DOI":"10.2174\/157488610789869166","article-title":"Prokinetic agents and QT prolongation: a familiar scene with new actors","volume":"5","author":"GA Keller","year":"2010","journal-title":"Curr Drug Saf"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1111\/j.1751-2980.2011.00491.x","article-title":"Cisapride: what can we learn from the rise and fall of a prokinetic?","volume":"12","author":"EM Quigley","year":"2011","journal-title":"J Dig Dis"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1111\/j.1365-2125.2008.03249.x","article-title":"Cisapride and ventricular arrhythmia","volume":"66","author":"S Hennessy","year":"2008","journal-title":"Br J Clin Pharmacol"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/j.jpeds.2008.06.009","article-title":"Domperidone-induced QT prolongation: add another drug to the list","volume":"153","author":"KK Collins","year":"2008","journal-title":"J Pediatr"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1046\/j.1365-2036.1999.00655.x","article-title":"Review article: cardiac adverse effects of gastrointestinal prokinetics","volume":"13","author":"M Tonini","year":"1999","journal-title":"Aliment Pharmacol Ther"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1016\/j.jacc.2007.02.020","article-title":"Evidence-based guidelines for cardiovascular disease prevention in women: 2007 update","volume":"49","author":"L Mosca","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S0025-7125(16)30179-1","article-title":"Secondary causes of hyperlipidemia","volume":"78","author":"N Stone","year":"1994","journal-title":"Med Clin North Am"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1016\/j.clinthera.2011.09.009","article-title":"Incidence and US costs of corticosteroid-associated adverse events: a systematic literature review","volume":"33","author":"E Sarnes","year":"2011","journal-title":"Clin Ther"},{"key":"ref55","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1016\/j.resuscitation.2010.06.025","article-title":"Pharmacotherapy and hospital admissions before out-of-hospital cardiac arrest: a nationwide study","volume":"81","author":"P Weeke","year":"2010","journal-title":"Resuscitation"},{"key":"ref56","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1055\/s-0029-1222610","article-title":"Psoriasis and atherothrombotic diseases: disease-specific and non-disease-specific risk factors","volume":"35","author":"P Gisondi","year":"2009","journal-title":"Semin Thromb Hemost"},{"key":"ref57","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1196\/annals.1422.036","article-title":"Accelerated atherosclerosis in rheumatoid arthritis","volume":"1108","author":"Z Szekanecz","year":"2007","journal-title":"Ann N Y Acad Sci"},{"key":"ref58","doi-asserted-by":"crossref","first-page":"878","DOI":"10.7326\/0003-4819-116-10-878_1","article-title":"Hyperglycemia induced by megestrol acetate","volume":"116","author":"AP Panwalker","year":"1992","journal-title":"Ann Intern Med"},{"key":"ref59","doi-asserted-by":"crossref","first-page":"53","DOI":"10.7326\/0003-4819-116-1-53","article-title":"Diabetes mellitus induced by megestrol acetate in a patient with AIDS and cachexia","volume":"116","author":"K Henry","year":"1992","journal-title":"Ann Intern Med"},{"key":"ref60","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1097\/00042560-199801010-00007","article-title":"Severe hyperglycemia in an HIV clinic: preexisting versus drug-associated diabetes mellitus","volume":"17","author":"JM Kilby","year":"1998","journal-title":"J Acquir Immune Defic Syndr Hum Retrovirol"},{"key":"ref61","doi-asserted-by":"crossref","first-page":"1632","DOI":"10.1592\/phco.22.17.1632.34129","article-title":"Probable case of torsades de pointes induced by fluconazole","volume":"22","author":"M Khazan","year":"2002","journal-title":"Pharmacotherapy"},{"key":"ref62","doi-asserted-by":"crossref","first-page":"619","DOI":"10.2146\/ajhp070203","article-title":"Torsades de pointes in a patient receiving fluconazole for cerebral cryptococcosis","volume":"65","author":"JH McMahon","year":"2008","journal-title":"Am J Health Syst Pharm"},{"key":"ref63","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1128\/AAC.35.4.707","article-title":"High-dose itraconazole in the treatment of severe mycoses","volume":"35","author":"PK Sharkey","year":"1991","journal-title":"Antimicrob Agents Chemother"},{"key":"ref64","doi-asserted-by":"crossref","first-page":"1766","DOI":"10.1016\/S0140-6736(00)04891-1","article-title":"Congestive heart failure associated with itraconazole","volume":"357","author":"SR Ahmad","year":"2001","journal-title":"Lancet"},{"key":"ref65","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/S1054-3589(08)60129-5","article-title":"Clinical pharmacology of systemic antifungal agents: a comprehensive review of agents in clinical use, current investigational compounds, and putative targets for antifungal drug development","volume":"44","author":"AH Groll","year":"1998","journal-title":"Adv Pharmacol"},{"key":"ref66","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1086\/598327","article-title":"Clinical relevance of the pharmacokinetic interactions of azole antifungal drugs with other coadministered agents","volume":"48","author":"AJ Br\u00fcggemann RJ","year":"2009","journal-title":"Clin Infect Dis"},{"key":"ref67","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1016\/S0140-6736(00)02799-9","article-title":"Adverse drug reactions: definitions, diagnosis, and management","volume":"356","author":"IR Edwards","year":"2000","journal-title":"Lancet"},{"key":"ref68","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S0300-483X(00)00303-6","article-title":"Advances in molecular toxicology-towards understanding idiosyncratic drug toxicity","volume":"153","author":"BK Park","year":"2000","journal-title":"Toxicology"}],"updated-by":[{"DOI":"10.1371\/annotation\/8824e161-bf8f-4f78-81e0-a62a1540276d","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2013,9,23]],"date-time":"2013-09-23T00:00:00Z","timestamp":1379894400000}}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0072148","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,4]],"date-time":"2023-07-04T01:03:27Z","timestamp":1688432607000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0072148"}},"subtitle":[],"editor":[{"given":"Aditya Bhushan","family":"Pant","sequence":"first","affiliation":[]}],"short-title":[],"issued":{"date-parts":[[2013,8,28]]},"references-count":68,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2013,8,28]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0072148","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.718101906.793487758","asserted-by":"object"}]},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,8,28]]}}}